Chemoinformaics analysis of 2,5-Dimethyl-3,4-hexanediol
Molecular Weight | 146.23 | nRot | 3 |
Heavy Atom Molecular Weight | 128.086 | nRig | 0 |
Exact Molecular Weight | 146.131 | nRing | 0 |
Solubility: LogS | -1.005 | nHRing | 0 |
Solubility: LogP | 1.121 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 26.9663 |
nHD | 2 | BPOL | 18.0577 |
QED | 0.624 |
Synth | 3.098 |
Natural Product Likeliness | 0.595 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.03 |
HIA | 0.015 |
CACO-2 | -4.445 |
MDCK | 0.0000331 |
BBB | 0.758 |
PPB | 0.550553 |
VDSS | 1.128 |
FU | 0.444792 |
CYP1A2-inh | 0.047 |
CYP1A2-sub | 0.155 |
CYP2c19-inh | 0.01 |
CYP2c19-sub | 0.841 |
CYP2c9-inh | 0.013 |
CYP2c9-sub | 0.625 |
CYP2d6-inh | 0.003 |
CYP2d6-sub | 0.286 |
CYP3a4-inh | 0.004 |
CYP3a4-sub | 0.272 |
CL | 11.661 |
T12 | 0.518 |
hERG | 0.015 |
Ames | 0.011 |
ROA | 0.067 |
SkinSen | 0.055 |
Carcinogencity | 0.028 |
EI | 0.818 |
Respiratory | 0.05 |
NR-Aromatase | 0.002 |
Antiviral | No |
Prediction | 0.933157 |